Valuation: Bayer AG

Market Cap 45.25B 51.56B 42.07B 38.62B 72.64B 4,966B 73.61B 500B 195B 2,441B 193B 189B 8,436B P/E 2026 *
19.9x
P/E 2027 * 14.9x
Enterprise Value 77.09B 87.84B 71.67B 65.8B 124B 8,460B 125B 852B 333B 4,158B 330B 323B 14,372B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.58x
Free-Float
100%
Yield 2026 *
0.5%
Yield 2027 * 1.37%
1 day-0.30%
1 week-4.95%
Current month-4.85%
1 month-2.00%
3 months+19.64%
6 months+3.38%
Current year+24.45%
1 week 45.49
Extreme 45.49
48.28
1 month 45.41
Extreme 45.41
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap.
3/18/26 A Buy

Chairman

2,671 0.0003%
3/18/26 A Buy

Chief Executive Officer

21,050 0.0021%
3/18/26 A Buy

Director

1,900 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%-4.95%+57.69%-10.96% 51.52B
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.41%+0.70%+29.35%+46.03% 369.5B
Weighted average by Cap. +0.75%+1.85%+36.30%+76.90%

Financials

2026 *2027 *
Net sales 45.6B 51.96B 42.4B 38.92B 73.21B 5,005B 74.19B 504B 197B 2,460B 195B 191B 8,502B 46.76B 53.28B 43.47B 39.91B 75.06B 5,131B 76.06B 517B 202B 2,522B 200B 196B 8,717B
Net income 2.13B 2.42B 1.98B 1.81B 3.41B 233B 3.46B 23.5B 9.18B 115B 9.09B 8.89B 396B 2.93B 3.34B 2.73B 2.5B 4.71B 322B 4.77B 32.41B 12.66B 158B 12.54B 12.27B 547B
Net Debt 31.84B 36.28B 29.6B 27.18B 51.11B 3,494B 51.8B 352B 137B 1,718B 136B 133B 5,936B 28.71B 32.72B 26.69B 24.51B 46.09B 3,151B 46.71B 317B 124B 1,549B 123B 120B 5,353B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
24/07/26 €46.06 -0.30% 1,486,549
23/07/26 €46.20 -1.64% 2,346,811
22/07/26 €46.97 -1.36% 1,856,037
21/07/26 €47.62 +0.66% 1,471,496
20/07/26 €47.31 -2.37% 1,487,548
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.06EUR
Average target price
54.92EUR
Spread / Average Target
+19.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock